SEC Form 4 · accession 0001102624-15-000419
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Jemil Esber
Director
Period of report
Sep 25, 2014
Accepted (ET)
Mar 20, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2015 | P | 9,000 | $0.20 | A | 13,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.37 | Sep 25, 2014 | A | 6,000 | A | Sep 25, 2014 | Sep 25, 2024 | Common Stock | 6,000 | 228,000 | D |